The French Government Defence procurement agency invests €900,000 towards Pherecydes Pharma managed €1.2-million project, involving several university and military laboratories.
Pherecydes Pharma is attending the Forum coorganised by PHAG ESPOIRS and LE LIEN associations, as well as their partners, Narbonne Hospital and City, on January 25, 2012 in Narbonne - France, at 9h15, in Le Théatre.
Biotech Finance press details the purpose of this investiment targeting the set up of a phage bioproduction unit and testing of 2 therapeutic products in human clinical trials.
Meeting the Belgian biotech companies at the 2011 Forum Bio-Entrepreneurs held in the Bourse de Commerce de Paris, December 6, 2011.
News & Information
The French Government Defence procurement agency invests €900,000 towards Pherecydes Pharma managed €1.2-million project, involving several university and military laboratories.
The full text of the press release is available by clicking on the following link.
Internet media coverage resulting from the announcement is available hereunder:
- BioSpace (US)
- Technology Networks (UK)
- PharmaLive (US)
- Defence professionnals (DE)
Pherecydes Pharma is attending the Forum coorganised by PHAG ESPOIRS and LE LIEN associations, as well as their partners, Narbonne Hospital and City, on January 25, 2012 in Narbonne - France, at 9h15, in Le Théatre.
Doctor Jérôme Larché, Président of PHAG ESPOIRS Association, has invited several patient associations and clinicians to discuss about antibiotic resistance and bacteriophage based treatments. The program of this free forum, open to the public, is dowloadable by clicking on the following link.
Biotech Finance press details the purpose of this investiment targeting the set up of a phage bioproduction unit and testing of 2 therapeutic products in human clinical trials.
Isabelle Martin from Biotech Finance newsroom recently conducted an interview with the CEO of Pherecydes Pharma, Jerome Gabard and Delphine, Dinard Director of Investment of ACE Management, which supports the development of the startup. Details about this discussion are summarized in the attached paper.
Meeting the Belgian biotech companies at the 2011 Forum Bio-Entrepreneurs held in the Bourse de Commerce de Paris, December 6, 2011.
Pherecydes Pharma left Bio-Entrepreneurs 2011 with a harvest of successfull business meetings. Asked by Isabelle Pottier, head of the biotechnology / health department of the Chamber of Commerce and Industry of Paris, which co-organized the event, Jerome Gabard stated: "The B2B meetings have been fruitful and concrete prospects of cooperation between our company and various Belgian firms are possible in the short term. We are delighted by this tenth edition put together by Centrale Santé and Enterprise Europe Network."